Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
- Specification
- Q & A
- Customer Review
Challenges include tumor heterogeneity, drug resistance, and the need to identify specific molecular targets that drive tumor growth.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
Convenient
The tumor cells I bought were all healthy and had the expected characteristics. This made my experiments much easier.
08 July 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: The HeLa 382 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 382 cell line was transfected with pBact, expression vector under control of the human beta actin promotor, resistant to G418S. Control to HeLa 422 and HeLa 432.
Description: The HeLa 422 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 422 cell line was transfected with ER-pBact, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.;
Description: Transfected with the exon 4 defective variant of ER-pBact cDNA, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.
Species: human, Black female 31 years old
Tissue: cervix
Tumor: carcinoma, epitheloid
Original line: HeLa
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
